Iovance Biotherapeutics To Present Clinical Data For Tumor Infiltrating Lymphocyte Cell Therapies Across Multiple Solid Tumors And Treatment Settings At The Society For Immunotherapy Of Cancer's 36th Annual Meeting Nov. 13